Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TGM2 | P21980 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL196271 | 0.97 | TSHR (0.54) | TSHRALDH1A1MAPK1TDP1CYP2C19 | |
| SCHEMBL4108692 | 0.81 | TSHR (0.59) | TSHRALDH1A1MAPK1TDP1CYP2C19 | |
| SCHEMBL7740515 | 0.79 | TSHR (0.38) | TSHRALDH1A1MAPK1TDP1CYP2C19 | |
| SCHEMBL2437423 | 0.77 | TSHR (0.54) | TSHRALDH1A1MAPK1TDP1CYP2C19 | |
| SCHEMBL36707 | 0.75 | TSHR (0.52) | TSHRALDH1A1MAPK1TDP1CYP2C19 | |
| SCHEMBL6416447 | 0.75 | TSHR (0.52) | TSHRALDH1A1MAPK1TDP1CYP2C19 | |
| SCHEMBL1081350 | 0.73 | TSHR (0.62) | TSHRALDH1A1MAPK1TDP1CYP2C19 | |
| SCHEMBL9316415 | 0.73 | TSHR (0.56) | TSHRALDH1A1MAPK1TDP1CYP2C19 | |
| Water SCHEMBL851923 | 0.73 | TSHR (0.50) | TSHRALDH1A1MAPK1TDP1CYP2C19 | |
| SCHEMBL1488255 | 0.73 | TSHR (0.50) | TSHRALDH1A1MAPK1TDP1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0501846-B1 | Process for coating paper and cardboard, and its use to make paper having a good smoothness | HOECHST FRANCE (FR) | 1995-04-26 | — | — | EP | claimed |
| US-5219619-A | Coating with acrylic acid homo- or copolymer crosslinked with bisacrylamidoacetic acid | SOCIETE FRANCAISE HOECHST (FR) | 1993-06-15 | — | — | US | claimed |
| EP-0325065-B1 | WATER-IN-OIL DISPERSIONS OF HYDROPHILIC POLYMERS BASED ON ACRYLIC ACID PARTIALLY OR FULLY NEUTRALISED WITH AMMONIA, PROCESS FOR THEIR PREPARATION AND THEIR USE IN PRINTING INK | SOCIETE FRANCAISE HOECHST Société anonyme dite: (FR) | 1992-07-22 | — | — | EP | claimed |
| US-4906685-A | Water in oil dispersions of hydrophilic polymers based on acrylic acid partially or totally converted into the salt form with ammonia | SOCIETE FRANCAISE HOECHST (FR) | 1990-03-06 | — | — | US | claimed |
| US-20050129769-A1 | Polymeric articles for carrying therapeutic agents | ALNIS BIOSCIENCES, INC. | 2005-06-16 | — | — | US | disclosed |
| EP-1531868-A2 | THERAPEUTIC AGENT-CONTAINING POLYMERIC NANOARTICLES | Alnis Biosciences, Inc. (US) | 2005-05-25 | — | — | EP | disclosed |
| WO-2005027873-A2 | THERAPEUTIC AMINOGLYCOSIDE-CONTAINING HYDROGEL NANOPARTICLES | ALNIS BIOSCIENCES, INC. (US) | 2005-03-31 | — | — | WO | disclosed |
| US-20040126900-A1 | High affinity peptide- containing nanoparticles | ALNIS BIOSCIENCES INC. | 2004-07-01 | — | — | US | disclosed |
| US-20040058006-A1 | High affinity nanoparticles | ALNIS BIOSCIENCES, INC. | 2004-03-25 | — | — | US | disclosed |
| WO-2003101425-A2 | THERAPEUTIC AGENT-CONTAINING POLYMERIC NANOARTICLES | ALNIS BIOSCIENCES, INC. (US) | 2003-12-11 | — | — | WO | disclosed |
| EP-1276507-A2 | HIGH AFFINITY PEPTIDE-CONTAINING NANOPARTICLES | Alnis Biosciences, Inc. (US) | 2003-01-22 | — | — | EP | disclosed |
| WO-2001078786-A2 | HIGH AFFINITY PEPTIDE-CONTAINING NANOPARTICLES | ALNIS BIOSCIENCES, INC. (US) | 2001-10-25 | — | — | WO | disclosed |
| US-6217901-B1 | POLYMERIZING POLYMER AND LIPOSOMES | ALNIS, LLC | 2001-04-17 | — | — | US | disclosed |
| US-5219619-A | Coating with acrylic acid homo- or copolymer crosslinked with bisacrylamidoacetic acid | SOCIETE FRANCAISE HOECHST (FR) | 1993-06-15 | — | — | US | disclosed |
| US-4906685-A | Water in oil dispersions of hydrophilic polymers based on acrylic acid partially or totally converted into the salt form with ammonia | SOCIETE FRANCAISE HOECHST (FR) | 1990-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050129769-A1 | Polymeric articles for carrying therapeutic agents | CD44, EPCAM, CLTB | TSHR 1664/4885ALDH1A1 3816/4885MAPK1 4417/4885 |
| US-20040126900-A1 | High affinity peptide- containing nanoparticles | LNPEP, IAPP, ACP1 | TSHR 1840/4885ALDH1A1 4525/4885MAPK1 2743/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.